1. Home
  2. SRDX vs IRMD Comparison

SRDX vs IRMD Comparison

Compare SRDX & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • IRMD
  • Stock Information
  • Founded
  • SRDX 1979
  • IRMD 1992
  • Country
  • SRDX United States
  • IRMD United States
  • Employees
  • SRDX N/A
  • IRMD N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • IRMD Medical/Dental Instruments
  • Sector
  • SRDX Health Care
  • IRMD Health Care
  • Exchange
  • SRDX Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • SRDX 562.6M
  • IRMD 618.5M
  • IPO Year
  • SRDX 1998
  • IRMD 2014
  • Fundamental
  • Price
  • SRDX $38.61
  • IRMD $51.99
  • Analyst Decision
  • SRDX Hold
  • IRMD Strong Buy
  • Analyst Count
  • SRDX 4
  • IRMD 1
  • Target Price
  • SRDX $43.00
  • IRMD $60.00
  • AVG Volume (30 Days)
  • SRDX 219.6K
  • IRMD 36.4K
  • Earning Date
  • SRDX 11-06-2024
  • IRMD 10-31-2024
  • Dividend Yield
  • SRDX N/A
  • IRMD 1.15%
  • EPS Growth
  • SRDX N/A
  • IRMD 13.16
  • EPS
  • SRDX N/A
  • IRMD 1.46
  • Revenue
  • SRDX $126,078,000.00
  • IRMD $71,305,130.00
  • Revenue This Year
  • SRDX $13.75
  • IRMD $13.29
  • Revenue Next Year
  • SRDX $13.67
  • IRMD $10.76
  • P/E Ratio
  • SRDX N/A
  • IRMD $35.61
  • Revenue Growth
  • SRDX N/A
  • IRMD 13.23
  • 52 Week Low
  • SRDX $25.17
  • IRMD $40.05
  • 52 Week High
  • SRDX $42.44
  • IRMD $57.95
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 50.28
  • IRMD 48.18
  • Support Level
  • SRDX $37.86
  • IRMD $55.40
  • Resistance Level
  • SRDX $38.93
  • IRMD $57.95
  • Average True Range (ATR)
  • SRDX 0.40
  • IRMD 2.33
  • MACD
  • SRDX 0.08
  • IRMD -0.04
  • Stochastic Oscillator
  • SRDX 62.29
  • IRMD 46.26

About SRDX Surmodics Inc.

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: